Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Thomas King, MS MPH

SCYNEXIS, Inc.

Disclosure(s): SCYNEXIS, Inc.: employee, Stocks/Bonds

Poster(s):

466 - All-Cause Mortality in Patients with Invasive Candidiasis or Candidemia from an Interim Analysis of a Phase 3 Open-label Study (FURI)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET